Equities
  • Price (EUR)0.272
  • Today's Change-0.002 / -0.55%
  • Shares traded2.37k
  • 1 Year change-67.46%
  • Beta0.1898
Data delayed at least 15 minutes, as of Mar 05 2026 07:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in NOKIncome statement in NOKView more

Year on year Elliptic Laboratories ASA's revenues fell -23.20% from 131.91m to 101.31m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 8.96m to a loss of 138.17m.
Gross margin--
Net profit margin-82.32%
Operating margin-8.33%
Return on assets-38.28%
Return on equity-43.30%
Return on investment-41.75%
More ▼

Cash flow in NOKView more

In 2025, cash reserves at Elliptic Laboratories ASA fell by 33.33m. However, the company earned 5.99m from its operations for a Cash Flow Margin of 5.92%. In addition the company used 26.86m on investing activities and also paid 10.31m in financing cash flows.
Cash flow per share-0.8383
Price/Cash flow per share--
Book value per share1.80
Tangible book value per share1.12
More ▼

Balance sheet in NOKView more

Elliptic Laboratories ASA appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio5.61
Quick ratio--
Total debt/total equity0.0691
Total debt/total capital0.0646
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.